Lombard Odier Asset Management (USA)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-19,499
Closed -$621K 245
2017
Q2
$621K Hold
19,499
0.05% 208
2017
Q1
$633K Sell
19,499
-13,175
-40% -$415K 0.06% 186
2016
Q4
$1.01M Buy
+32,674
New +$997K 0.13% 130
2015
Q4
Sell
-198,152
Closed -$5.91M 184
2015
Q3
$5.91M Buy
+198,152
New +$6.35M 0.52% 68

Other funds holding PFE

Lombard Odier Asset Management (USA)'s PFE Position: Q3 2017 in Review

Lombard Odier Asset Management (USA) sold out of Pfizer (PFE) in Q3 2017, closing a stake of 19,499 shares — an estimated $621K sold.

Lombard Odier Asset Management (USA) first reported a position in PFE in Q3 2015 and held it in 4 quarters. The position peaked at $5.91M in Q3 2015. 2,040 funds tracked by Wall St. Rank hold PFE as of Q3 2017.

  • Lombard Odier Asset Management (USA) reported no remaining Pfizer position as of Q3 2017 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 19,499 Pfizer shares in Q3 2017, an estimated $621K.
  • Lombard Odier Asset Management (USA) first reported a position in Pfizer in Q3 2015 and held it in 4 quarters.
  • Lombard Odier Asset Management (USA)'s Pfizer position peaked at $5.91M in Q3 2015.
  • 2,040 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q3 2017, filed 14 Nov 2017.